I have no idea what innovation looks like in PRS. ML is all good but the bottleneck is (presumably) phenotyping which none of these companies want to do.
Okay, I should probably caveat this by saying that Google does have a phenotyping service in the sense of Google Health and related products, but I’m not aware of any work in this area and I’m not sure how much things like heart rate/BMI etc. are usable in genomic research. Or that they can even be released to be used in this way.
I have no idea what innovation looks like in PRS. ML is all good but the bottleneck is (presumably) phenotyping which none of these companies want to do.
Okay, I should probably caveat this by saying that Google does have a phenotyping service in the sense of Google Health and related products, but I’m not aware of any work in this area and I’m not sure how much things like heart rate/BMI etc. are usable in genomic research. Or that they can even be released to be used in this way.